Insider Transactions in Q1 2025 at Ranpak Holdings Corp. (PACK)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2025
|
William Drew Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
3,819
-0.7%
|
$22,914
$6.02 P/Share
|
|
Mar 17
2025
|
William Drew Chief Financial Officer & EVP |
BUY
Grant, award, or other acquisition
|
Direct |
30,675
+5.33%
|
-
|
|
Mar 17
2025
|
Omar Asali CEO & Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
14,216
-0.52%
|
$85,296
$6.02 P/Share
|
|
Mar 17
2025
|
Omar Asali CEO & Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
92,027
+3.24%
|
-
|
|
Mar 17
2025
|
Mark A. Siebert MD, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
2,372
-2.12%
|
$14,232
$6.02 P/Share
|
|
Mar 17
2025
|
Mark A. Siebert MD, North America |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+15.48%
|
-
|
|
Mar 17
2025
|
Eric Laurensse Managing Director, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
5,785
-2.73%
|
$34,710
$6.02 P/Share
|
|
Mar 17
2025
|
Eric Laurensse Managing Director, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
35,058
+14.2%
|
-
|
|
Mar 17
2025
|
Antonio Grassotti Managing Director, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
20,344
+9.72%
|
-
|
|
Mar 17
2025
|
Michael S. Gliedman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,457
-1.59%
|
$14,742
$6.02 P/Share
|
|
Mar 17
2025
|
Michael S. Gliedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,529
+10.16%
|
-
|
|
Mar 10
2025
|
William Drew Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
9,620
-1.84%
|
$48,100
$5.72 P/Share
|
|
Mar 10
2025
|
Michael S. Gliedman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,154
-4.28%
|
$30,770
$5.72 P/Share
|
|
Mar 10
2025
|
Eric Laurensse Managing Director, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
14,573
-7.62%
|
$72,865
$5.72 P/Share
|
|
Mar 10
2025
|
Mark A. Siebert MD, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
6,969
-7.08%
|
$34,845
$5.72 P/Share
|
|
Mar 10
2025
|
Omar Asali CEO & Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
32,877
-1.22%
|
$164,385
$5.72 P/Share
|
|
Mar 04
2025
|
Antonio Grassotti Managing Director, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
18,309
+9.8%
|
-
|
|
Mar 04
2025
|
Eric Laurensse Managing Director, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
31,552
+14.16%
|
-
|
|
Mar 04
2025
|
Omar Asali CEO & Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
92,026
+3.31%
|
-
|
|
Mar 04
2025
|
William Drew Chief Financial Officer & EVP |
BUY
Grant, award, or other acquisition
|
Direct |
30,675
+5.53%
|
-
|
|
Mar 04
2025
|
Mark A. Siebert MD, North America |
BUY
Grant, award, or other acquisition
|
Direct |
18,450
+15.79%
|
-
|
|
Mar 04
2025
|
Michael S. Gliedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+14.83%
|
-
|
|
Jan 02
2025
|
Michael S. Gliedman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
8,287
-6.53%
|
$49,722
$6.78 P/Share
|
|
Jan 02
2025
|
Omar Asali CEO & Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
46,153
-1.75%
|
$276,918
$6.78 P/Share
|
|
Jan 02
2025
|
Salil Seshadri Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,765
+0.54%
|
$16,590
$6.78 P/Share
|
|
Jan 02
2025
|
K. El Pamela Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,765
+2.7%
|
$16,590
$6.78 P/Share
|
|
Jan 02
2025
|
Michael Anthony Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,765
+1.22%
|
$16,590
$6.78 P/Share
|
|
Jan 02
2025
|
William Drew Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
14,414
-2.84%
|
$86,484
$6.78 P/Share
|
|
Jan 02
2025
|
Alicia M. Tranen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,765
+1.08%
|
$16,590
$6.78 P/Share
|
|
Jan 02
2025
|
Eric Laurensse Managing Director, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
12,375
-7.19%
|
$74,250
$6.78 P/Share
|
|
Jan 02
2025
|
Mark A. Siebert MD, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
8,000
-9.1%
|
$48,000
$6.78 P/Share
|